Corify Strengthens Its Commitment to Science and Talent Through the Torres Quevedo Program
Corify Care continues to reinforce its long-term commitment to scientific excellence and innovation with the recognition of three of its researchers — Ernesto, Rubén, and Ismael — under Spain’s prestigious Torres Quevedo Program, a national initiative that supports postdoctoral researchers in their transition from academia to industry.
This highly competitive program, funded by the Spanish Ministry of Science, Innovation and Universities (MCIN) and the State Research Agency (AEI), rewards companies that drive technological advancement through deep scientific collaboration and applied research.
For Corify, this recognition represents more than an individual success — it reflects the company’s sustained investment in R&D, engineering, and clinical science, and its belief that scientific talent is the foundation for transforming the diagnosis and treatment of cardiac arrhythmias.
With the support of the Torres Quevedo Program, Ernesto, Rubén, and Ismael will continue advancing projects that integrate noninvasive cardiac mapping, artificial intelligence, and clinical validation, accelerating the translation of innovation into real patient impact.
Corify’s paticipation in this program reinforces its mission to bridge the gap between research and clinical practice, ensuring that each technological advance is built on solid scientific evidence and designed to meet the needs of hospitals and clinicians worldwide.
Acknowledgements
Corify Care gratefully acknowledges the support of the Torres Quevedo Program, funded by the Spanish Ministry of Science, Innovation and Universities (MCIN) and the State Research Agency (AEI) MICIU/AEI /10.13039/501100011033, under the project references PTQ2022-012632, PTQ2023-013018, PTQ2023-012972.
